Advances in immunology: The HLA system (Second of two parts)

New England Journal of Medicine

Volumn 343, Issue 11, 2000, Pages 782-786

  Klein, Jan ^a   Sato, Akie ^a  

^a MAX PLANCK INST FÜR BIOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; GENETIC LINKAGE; HEMOCHROMATOSIS; HLA SYSTEM; HUMAN; INFECTION; MALIGNANT NEOPLASTIC DISEASE; NARCOLEPSY; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION; COMMUNICABLE DISEASE; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASM; PHYSIOLOGY;

HLA ANTIGEN;

AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS; TRANSPLANTATION IMMUNOLOGY;

EID: 0034648601     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200009143431106     Document Type: Review

References (48)

1. Immunodeficiency due to defective antigen processing: The molecular basis for type I bare lymphocyte syndrome
2. Splice acceptor site mutation of the transporter associated with antigen processing-1 gone in human bare lymphocyte syndrome
3. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1
4. The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes
5. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
6. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
7. Disorders of iron metabolism
8. Iron overload: Molecular clues to its cause
9. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
10. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor
11. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
12. Haplotype analysis of hemochromatosis: Evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes
13. The immunogenetics of human infectious diseases
14. Common West African HLA antigens are associated with protection from severe malaria
15. Molecular analysis of the association of HLA-B53 and resistance to severe malaria
16. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
17. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
18. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
19. Association of malaria parasite population structure, HLA, and immunological antagonism
20. Autoimmunity
21. Invited anniversary review: HLA associated diseases
22. Guilt by association: HLA-B27 and ankylosing spondylitis
23. The pathogenetic role of HLA-B27
24. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression
25. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes
26. Autoimmunity against desmosomal cadherins in pemphigus
27. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris
28. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris
29. A new era for cancer immunotherapy based on the genes that encode cancer antigens
30. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors
31. Natural killer cell activation and inhibition by receptors for MHC class I
32. Cellular and molecular mechanisms of allograft rejection
33. Direct and indirect recognition: The role of MHC antigens in graft rejection
34. The molecular basis of allorecognition: Assessment of the involvement of peptide
35. Role of indirect allorecognition in allograft rejection
36. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone
37. Structural basis of T cell recognition
38. Minor histocompatibility antigens
39. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
40. HLA-peptide tetrameric complexes
41. The arrival of HLA class II tetramers
42. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes
43. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen
44. Phenotypic analysis of antigen-specific T lymphocytes
45. Prospects for adoptive T cell therapy
46. Altered peptide ligand design: Altering immune responses to class I MHC/peptide complexes